Novo Nordisk
NVO
#100
Rank
NZ$333.72 B
Marketcap
NZ$75.54
Share price
0.12%
Change (1 day)
-28.44%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

ESG Reports

Thumbnail Novo Nordisk ESG Report 2024

ESG Report 2024

Language: English

View ESG Report